Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9486)
All Articles published online
|
Publishing Process of This Article
|
Apr 15, 2017 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Galanopoulos M, Tsoukalas N, Papanikolaou IS, Tolia M, Gazouli M, Mantzaris GJ. Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature. World J Gastrointest Oncol 2017; 9(4): 142-152 [PMID: 28451061 DOI: 10.4251/wjgo.v9.i4.142] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i4/142.htm |
| Number | Citing Articles |
| 1 |
Xiaohui Sun, Diyu Chen, Ziqi Jin, Tianhui Chen, Aifen Lin, Hongchuan Jin, Yimin Zhu, Maode Lai. Genome-wide methylation and expression profiling identify methylation-associated genes in colorectal cancer. Epigenomics 2020; 12(1): 19 doi: 10.2217/epi-2019-0133
|
| 2 |
María Gallardo-Gómez, Paula Álvarez-Chaver, Alberto Cepeda, Patricia Regal, Alexandre Lamas, Loretta De Chiara. Foundations of Colorectal Cancer. 2022; : 249 doi: 10.1016/B978-0-323-90055-3.00004-1
|
| 3 |
Ihsan Ullah, Le Yang, Feng-Ting Yin, Ye Sun, Xing-Hua Li, Jing Li, Xi-Jun Wang. Multi-Omics Approaches in Colorectal Cancer Screening and Diagnosis, Recent Updates and Future Perspectives. Cancers 2022; 14(22): 5545 doi: 10.3390/cancers14225545
|
| 4 |
Elham Kashani, Mahrooyeh Hadizadeh, Vahid Chaleshi, Reza Mirfakhraie, Chris Young, Sanaz Savabkar, Shiva Irani, Hamid Asadzadeh Aghdaei, Maziar Ashrafian Bonab. The Differential DNA Hypermethylation Patterns of microRNA-137 and microRNA-342 Locus in Early Colorectal Lesions and Tumours. Biomolecules 2019; 9(10): 519 doi: 10.3390/biom9100519
|
| 5 |
Amjad Mahasneh, Fawaz Al-Shaheri, Eshraq Jamal. Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updates. Experimental and Molecular Pathology 2017; 102(3): 475 doi: 10.1016/j.yexmp.2017.05.005
|
| 6 |
Bin Li, Ranran Pan, Cong Zhou, Jie Dai, Yiyi Mao, Min Chen, Tianyi Huang, Xiuru Ying, Haochang Hu, Jun Zhao, Wei Zhang, Shiwei Duan. SMYD3 promoter hypomethylation is associated with the risk of colorectal cancer. Future Oncology 2018; 14(18): 1825 doi: 10.2217/fon-2017-0682
|
| 7 |
Mahsa Akbari Oryani, Afsaneh Tavasoli, Mohammad Amin Ghalavand, Rahele Zokaei Ashtiani, Alisam Rezaee, Rasadokht Mahmoudi, Hossein Golvari, Soroor Owrangi, Mehdi Soleymani-Goloujeh. Epigenetics and its therapeutic potential in colorectal cancer. Epigenomics 2022; 14(11): 683 doi: 10.2217/epi-2022-0067
|
| 8 |
Danyi Wang, Dennis O’Rourke, Jorge F. Sanchez-Garcia, Ti Cai, Juergen Scheuenpflug, Zheng Feng. Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08497-x
|
| 9 |
María Gallardo-Gómez, Loretta De Chiara, Paula Álvarez-Chaver, Joaquin Cubiella. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method. Expert Review of Anticancer Therapy 2021; 21(7): 723 doi: 10.1080/14737140.2021.1882858
|
| 10 |
Shreya Singh Beniwal, Paula Lamo, Ajeet Kaushik, Dionisio Lorenzo Lorenzo-Villegas, Yuguang Liu, ArunSundar MohanaSundaram. Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics. Biosensors 2023; 13(10): 926 doi: 10.3390/bios13100926
|
| 11 |
Alberto Puccini, Martin D. Berger, Madiha Naseem, Ryuma Tokunaga, Francesca Battaglin, Shu Cao, Diana L. Hanna, Michelle McSkane, Shivani Soni, Wu Zhang, Heinz-Josef Lenz. Colorectal cancer: epigenetic alterations and their clinical implications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2017; 1868(2): 439 doi: 10.1016/j.bbcan.2017.09.003
|
| 12 |
E J Ryan, E M Creagh. Emerging methods in colorectal cancer screening. British Journal of Surgery 2018; 105(2): e16 doi: 10.1002/bjs.10650
|
| 13 |
Hui He, Di Chen, Shimeng Cui, Gang Wu, Hailong Piao, Xun Wang, Peng Ye, Shi Jin. HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma. BMC Medical Genomics 2020; 13(1) doi: 10.1186/s12920-020-00770-5
|
| 14 |
Guodong Zhao, Hui Li, Zixuan Yang, Zhenzhen Wang, Manqiu Xu, Shangmin Xiong, Shiming Li, XiaoTing Wu, Xiaoyu Liu, Ziwen Wang, Yun Zhu, Yong Ma, Sujuan Fei, Minxue Zheng. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening. Cancer Medicine 2019; 8(12): 5619 doi: 10.1002/cam4.2475
|
| 15 |
Bo Cao, Xin Zhou, Wanli Yang, Jiaojiao Ma, Wei Zhou, Daiming Fan, Liu Hong. The role of cell-free DNA in predicting colorectal cancer prognosis. Expert Review of Gastroenterology & Hepatology 2018; 12(1): 39 doi: 10.1080/17474124.2017.1372191
|
| 16 |
Gongping Sun, Jin Meng, He Duan, Dewei Zhang, Yuanxin Tang. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis. Pathology & Oncology Research 2019; 25(4): 1525 doi: 10.1007/s12253-018-0559-5
|
| 17 |
Ji Taek Hong, Eun Ran Kim. Current state and future direction of screening tool for colorectal cancer. World Journal of Meta-Analysis 2019; 7(5): 184-208 doi: 10.13105/wjma.v7.i5.184
|
| 18 |
María Gallardo-Gómez, Mar Rodríguez-Girondo, Núria Planell, Sebastian Moran, Luis Bujanda, Ane Etxart, Antoni Castells, Francesc Balaguer, Rodrigo Jover, Manel Esteller, Joaquín Cubiella, David Gómez-Cabrero, Loretta De Chiara. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas. Clinical Epigenetics 2023; 15(1) doi: 10.1186/s13148-023-01570-1
|
| 19 |
Parisa Rokni, Afsaneh Mojtabanezhad Shariatpanahi, Ebrahim Sakhinia, Mohammad Amin Kerachian. BMP3 promoter hypermethylation in plasma-derived cell-free DNA in colorectal cancer patients. Genes & Genomics 2018; 40(4): 423 doi: 10.1007/s13258-017-0644-2
|
| 20 |
María Gallardo-Gómez, Sebastian Moran, María Páez de la Cadena, Vicenta Soledad Martínez-Zorzano, Francisco Javier Rodríguez-Berrocal, Mar Rodríguez-Girondo, Manel Esteller, Joaquín Cubiella, Luis Bujanda, Antoni Castells, Francesc Balaguer, Rodrigo Jover, Loretta De Chiara. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples. Clinical Epigenetics 2018; 10(1) doi: 10.1186/s13148-018-0487-y
|
| 21 |
Gabriele De Rubis, Sabna Rajeev Krishnan, Mary Bebawy. Circulating tumor DNA – Current state of play and future perspectives. Pharmacological Research 2018; 136: 35 doi: 10.1016/j.phrs.2018.08.017
|
| 22 |
Ramona G. Dumitrescu. Cancer Epigenetics for Precision Medicine. Methods in Molecular Biology 2018; 1856: 3 doi: 10.1007/978-1-4939-8751-1_1
|
| 23 |
Béla Molnár, Orsolya Galamb, Alexandra Kalmár, Barbara Kinga Barták, Zsófia Brigitta Nagy, Kinga Tóth, Zsolt Tulassay, Péter Igaz, Magdolna Dank. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update. Expert Review of Molecular Diagnostics 2019; 19(6): 477 doi: 10.1080/14737159.2019.1613891
|
| 24 |
Khadijeh Jamialahmadi, Marjan Azghandi, Ali Javadmanesh, Mahdi Zardadi, Ehsan Shams Davodly, Mohammad Amin Kerachian. A DNA methylation panel for high performance detection of colorectal cancer. Cancer Genetics 2021; : 64 doi: 10.1016/j.cancergen.2020.12.007
|